z-logo
open-access-imgOpen Access
Brain lesion distribution criteria distinguish demyelinating diseases in China
Author(s) -
Cai MengTing,
Zhang YinXi,
Zheng Yang,
Yang Fan,
Fang Wei,
Shen ChunHong,
Ding MeiPing
Publication year - 2019
Publication title -
annals of clinical and translational neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.824
H-Index - 42
ISSN - 2328-9503
DOI - 10.1002/acn3.50913
Subject(s) - medicine , lesion , demyelinating disease , pathology , disease
Abstract Objective To verify the utility of brain lesion distribution criteria in distinguishing multiple sclerosis (MS) from aquaporin‐4 (AQP4)‐immunoglobulin G (IgG)‐positive/‐negative neuromyelitis optica spectrum disorder (NMOSD) and myelin oligodendrocyte glycoprotein IgG‐associated encephalomyelitis (MOG‐EM) in the Chinese population. Methods A total of 253 patients with MS (80), NMOSD (129 AQP4‐IgG positive, 34 AQP4‐IgG negative), and MOG‐EM (10) were enrolled. Anonymized magnetic resonance imaging results were scored on the previous reported criteria of “at least one lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe; or the presence of a subcortical U‐fiber lesion; or a Dawson’s finger‐type lesion.” Chi‐squared test (or Fisher’s exact test) was used to analyze the data. Results The distribution criteria were able to distinguish MS with a same sensitivity of 93.8% from all type of NMOSD and MOG‐EM, with a specificity of 89.7% from the whole NMOSD cohort, 89.1% from AQP4‐IgG‐positive NMOSD 91.2% from AQP4‐IgG‐negative NMOSD, and 70.0% from MOG‐EM. Dawson's finger‐type lesion was the most sensitive and specific feature, whereas the U‐fiber lesion was the least. Conclusion The brain lesion distribution criteria were helpful in distinguishing MS from NMOSD and MOG‐EM in the Chinese population. Dawson's finger‐type lesion was highly suggestive of MS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here